On this episode of Stock Movers:
- T-Mobile (TMUS) shares fall after news that President Donald Trump is launching a Trump-branded mobile phone service, that will rely on wireless networks and hardware that is “made in America.”
- MGM (MGM) shares rise after sports betting joint venture BetMGM raised its net revenue and Ebitda guidance for fiscal year 2025, following strong second-quarter trading.
- Incyte (INCY) shares gain after the drugmaker gave clinical data from two trials of its experimental therapy to treat a blood disorder, which is impressing Wall Street.

On this episode of Stock Movers: - T-Mobile (TMUS) shares fall after news that President Donald Trump is launching a Trump-branded mobile phone service, that will rely on wireless networks and hardware that is &ldquo;made in America.&rdquo; - MGM (MGM) shares rise after sports betting joint venture BetMGM raised its net revenue and Ebitda guidance for fiscal year 2025, following strong second-quarter trading. - Incyte (INCY) shares gain after the drugmaker gave clinical data from two trials of its experimental therapy to treat a blood disorder, which is impressing Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

T-Mobile Falls, MGM Rises, Incyte Gains on Clinical Data

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/91a1ce33-bba5-46b1-8aad-b2fe00ead930/transcript